Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8866 to 8880 of 8929 results

  1. Thousands of appointments released for the NHS without compromising safety

    Delivering fewer radiotherapy sessions over a shorter period of time, first introduced during COVID, benefits patients and the system long-term

  2. Non-invasive weight loss procedure can be an option to treat obesity

    A procedure which reduces the size of the stomach by two-thirds to help people living with obesity to lose weight has been deemed safe and effective to be used in the NHS, NICE has said.

  3. Time to talk: about NICE's latest depression guidelines

    To mark Time to Talk Day (February 2) we spoke with Catherine Ruane, who acted as a carer for her father and sister, who both lived with depression.

  4. Emergency kits for people with adrenal insufficiency recommended to avoid hospital admission

    People with adrenal insufficiency should be given an emergency medical kit with potentially life-saving steroid injections, according to our new clinical guideline.

  5. Introducing a new way of prioritising our guidance topics

    NICE's deputy chief executive, Jonathan Benger, talks about our new approach to prioritisation.

  6. How NICE is ensuring its topic prioritisation decisions are grounded in lived experience

    Simon Denegri discusses NICE’s commitment to involving the public voice in its work and decisions.

  7. NICE collaboration on streamlined licensing and patient access process for new medicines

    Companies can now submit medicines for the new Innovative Licensing and Access Pathway (ILAP) following close collaboration between the NICE, drug regulators, the NHS and equivalent organisations in Scotland.

  8. Pembrolizumab plus chemotherapy not recommend for triple negative breast cancer

    Draft guidance published today (8 March 2022) by NICE does not recommend pembrolizumab plus chemotherapy for treating triple negative breast cancer

  9. How NICE manages the potential conflicts of interests of patient experts

    People with lived experience provide valuable insight into the impact of NICE’s’ guidance and advice.

  10. Women inspiring inclusion in NICE guidance

    This International Women’s Day, we’re focusing on the invaluable contributions of 2 of the women who help shape our guidance through their independent voluntary committee roles. They talk to us about their involvement with NICE and what #InspireInclusion means to them.

  11. Listening to patients and organisations to update NICE's quality standard on transition from children's to adults' services

    Melanie explains how the update to our quality standard on the transition from children’s to adults’ services will benefit young people, their families and carers.

  12. NICE sets out further details on menopause guideline update

    NICE has outlined what aspects of menopause care will be updated in upcoming guidance, including areas where more research is needed.

  13. International collaboration - advancing the use of real-world evidence in health technology assessment

    Dr Ravinder Claire outlines recent progress towards greater use of real-world evidence in regulatory decision-making. He also considers the implications and opportunities for NICE and our stakeholders.

  14. NICE's flexibility in evaluation of new health tech and fairer patient access

    Changes to the way medicines and other health technologies are evaluated by NICE for use in the NHS were approved by its Board.

  15. Celebrating the people who support NICE: International Volunteer Day

    Applauding the members of the public who donate their valuable experience and insight to NICE.